Literature DB >> 8210494

SR 48968, a neurokinin A (NK2) receptor antagonist.

X Emonds-Alt1, C Advenier, T Croci, L Manara, G Neliat, M Poncelet, V Proietto, V Santucci, P Soubrié, D Van Broeck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8210494     DOI： 10.1016/0167-0115(93)90008-v

Source DB:  PubMed          Journal:  Regul Pept        ISSN： 0167-0115


× No keyword cloud information.
  6 in total

1.  Regional variations in neurokinin receptor subtype contributions to muscularis mucosae and epithelial function in rat colon.

Authors:  Caroline B Appleyard; Marangelie Morales; William H Percy
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

2.  Functional evidence for NO-synthase activation by substance P through a mechanism not involving classical tachykinin receptors in guinea-pig ileum in vitro.

Authors:  R Garcia-Villar; C Dupuis; J P Martinolle; J Fioramonti; L Buéno
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

3.  Cardiovascular responses to intrathecal neuropeptide gamma in conscious rats: receptor characterization and mechanism of action.

Authors:  P Poulat; J de Champlain; R Couture
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

4.  Human colonic anti-secretory activity of the potent NK(1) antagonist, SR140333: assessment of potential anti-diarrhoeal activity in food allergy and inflammatory bowel disease.

Authors:  D Moriarty; J Goldhill; N Selve; D P O'Donoghue; A W Baird
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

5.  Chronic inflammation alters the contribution of neurokinin receptor subtypes to epithelial function in rat colon.

Authors:  Caroline B Appleyard; Marangelie Morales; Cariluz Santiago
Journal:  Dig Dis Sci       Date:  2007-05-18       Impact factor: 3.199

Review 6.  Using guinea pigs in studies relevant to asthma and COPD.

Authors:  Brendan J Canning; Yangling Chou
Journal:  Pulm Pharmacol Ther       Date:  2008-02-02       Impact factor: 3.410
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.